Scarica l'app Stockscreener
70.23
5.40%
3.60
Dopo l'orario di chiusura:
70.23
Solventum Corp Borsa (SOLV) Ultime notizie
Solventum, facing tariffs of up to $100 million, raises sales guidance - MSN
Solventum Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - simplywall.st
Decoding Solventum Corp (SOLV): A Strategic SWOT Insight - GuruFocus
Solventum beats first-quarter profit estimates on strong surgical product sales - MSN
Solventum (SOLV) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - MSN
Solventum beats The Street in Q1 and ups revenue guidance - MassDevice
Solventum Corp. stock rises Friday, outperforms market - MarketWatch
Solventum Corporation: Cheap, With Caveats (NYSE:SOLV) - Seeking Alpha
Solventum Stock Gains on Q1 Earnings & Revenue Beat, Margins Decline - Zacks Investment Research
Health care manufacturer Solventum faces $100 million tariff hit despite strong Q1 - The Business Journals
Solventum price target lowered to $78 from $80 at Piper Sandler - TipRanks
Solventum Q1 FY25 presentation: raises organic sales outlook despite tariff headwinds - Investing.com
Solventum: Q1 Earnings Snapshot - New Haven Register
Solventum Corp (SOLV) Q1 2025 Earnings Call Highlights: Strong Organic Growth Amid Tariff Challenges - Investing.com Canada
Solventum sees FY25 adjusted EPS $5.45-$5.65, consensus $5.54 - TipRanks
Earnings call transcript: Solventum’s Q1 2025 results show mixed performance - Investing.com
Solventum reports Q1 adjusted EPS $1.34, consensus $1.22 - TipRanks
Solventum Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Solventum (SOLV) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
Solventum to Participate in the 2025 BofA Securities Health Care Conference - GuruFocus
Solventum Q1 Adjusted Earnings Fall, Sales Rise; 2025 Outlook Reaffirmed - marketscreener.com
Solventum Corp Q1 2025 Earnings: EPS at $0.78, Revenue Hits $2.1 Billion - GuruFocus
Solventum Corporation Q1 Profit Decreases, But Beats Estimates - Nasdaq
Solventum Q1 Earnings Likely to Reflect Higher Costs & Expenses - MSN
Solventum Earnings: What To Look For From SOLV - Yahoo Finance
7 Analysts Assess Solventum: What You Need To Know - Benzinga
Solventum Corporation (SOLV): Among Billionaire Seth Klarman’s Stock Picks with Huge Upside Potential - Insider Monkey
Solventum price target lowered to $80 from $84 at Piper Sandler - TipRanks
Hologic Adds Wayde McMillan to its Board of Directors - Medical Product Outsourcing
Here's What to Expect From Solventum’s Next Earnings Report - Nasdaq
Here's What To Expect From Solventum’s Next Earnings Report - Barchart.com
Solventum Corporation (SOLV): Among the Best New Stocks to Buy According to Billionaires - MSN
Solventum Corporation (SOLV): Among Billionaire Nelson Peltz’s Stock Picks with Highest Upside Potential - Insider Monkey
Should You Be Excited About Solventum Corporation's (NYSE:SOLV) 16% Return On Equity? - simplywall.st
Solventum Stock Price, Quotes and Forecasts - Benzinga
Grin to Launch Digital Care Ecosystem at AAO 2025, Integrate with Clarity by Solventum - Orthodontic Products
Solventum to Report First Quarter Fiscal 2025 Earnings on May 8, 2025 - StreetInsider
Solventum Announces Historic First Earnings Release: What Financial Markets Are Watching - Stock Titan
Thermo Fisher acquires Solventum’s PF business in $4.1bn deal - Financier Worldwide
Solventum Corporation (NYSE:SOLV): Is the Spin-Off a Blessing in Disguise? - MSN
1.01%
0.78%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):